The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Earnings come in mixed as investors watch US data, Fed

Thu, 31st Jul 2014 12:04

- Shell, BG Group and Intu lead the risers- Weir, Schroders and Lloyds fall- Afren drops after suspending directors- US data and Fed keep investors cautioustechMARK 2,763.54 -0.57%FTSE 100 6,763.04 -0.15%FTSE 250 15,495.73 -0.86%London stocks were trading in the red for a second straight day on Thursday as investors gave a mixed reaction to a wave of blue-chip corporate earnings and showed their nerves amid policy tightening speculation in the States. Results from Shell, BG Group, Intu Properties impressed the market in morning trade, offset by falls from Weir, Schroders and Lloyds. Meanwhile, the share price of oil explorer Afren plummeted after the company suspended two directors.The FTSE 100 was down 0.15% at 6,763 around midday.The Federal Reserve decided on Wednesday night to taper stimulus by $10bn a month for the sixth straight time, putting the central bank on course to end its quantitative easing programme in October.However, with the end of monetary stimulus now fast approaching, Wednesday's better-than-expected US growth figures - economy expanded by 4% in second quarter - traders are now concerned that policymakers could be tempted to raise interest rates sooner than expected.Jasper Lawler, a market analyst at CMC Markets, said that Fed Chair Janet Yellen had aimed to be "dovish while demonstrating a gradual hawkish shift" in the Fed's statement on Wednesday. However, with growth above expectations and inflation running at the target 2% amid a strengthening labour market, he said the "markets didn't really buy the Fed's attempt at dovishness"."After growth and inflation, Friday's non-farm payrolls will be the third point in the rate hike 'triangle', another 200k+ report and unemployment below 6% means the Fed really have no excuses not to tighten," he said.The consensus forecast for the all-important 'official' US employment report is for a 231,000 gain in non-farm payrolls in July, down from an impressive 288,000 in June. The unemployment rate is expected to remain unchanged after falling to 6.1%, its lowest since September 2008.As for Thursday's session, the focus will be on weekly US initial jobless claims, which are predicted to have risen to 300,000 from a post-recession low of 284,000 the previous week.Earnings come in mixedOil major Royal Dutch Shell impressed with shares rising strongly after saying earnings more than doubled in the second quarter to $5.1bn, even when including a $1bn net charge due to impairments. Natural gas group BG Group was also higher as it lifted its interim by a tenth after a strong second quarter led to a 9% increase in earnings per share in the first half.Intu Properties was in favour after the real estate firm said higher rental income helped to lift underlying earnings as the letting market showed "encouraging signs of improvement".Heading the other way banking group Lloyds which underwhelmed after saying that underlying profits improved by 32% to £3.82bn in the first half of the year, ahead of the £3.6bn consensus forecast. This was achieved despite a 2.2% fall in total underlying income to £9.25bn.Engineer Weir was in the red after reporting that profits slid 6% in the first half, reflecting adverse foreign exchange currency exchange rate movements and challenging conditions in the mining industry. Even though it unexpectedly hiked its half-year dividend 50% to 24p, shares in asset manager Schroders slipped after it sounded a note of caution about the retail investor market. Meanwhile, telecoms group BT and drinks giant Diageo both rose after their results, while engine maker Rolls-Royce and drugs group AstraZeneca underwhelmed.On the FTSE 250, Afren shares plummeted after the company said that it has suspended its chief executive officer and chief operating officer as an investigation found "the receipt of unauthorised payments potentially for the benefit of the CEO and COO".FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,583.50p +3.80%Royal Dutch Shell 'A' (RDSA) 2,454.00p +3.00%Intu Properties (INTU) 328.60p +2.59%BG Group (BG.) 1,203.00p +1.91%BT Group (BT.A) 390.80p +0.75%GlaxoSmithKline (GSK) 1,435.00p +0.70%BP (BP.) 484.95p +0.66%Diageo (DGE) 1,799.00p +0.56%Antofagasta (ANTO) 820.50p +0.55%easyJet (EZJ) 1,297.00p +0.54%FTSE 100 - FallersWeir Group (WEIR) 2,556.00p -4.20%Schroders (SDR) 2,417.00p -3.28%St James's Place (STJ) 732.00p -3.05%Lloyds Banking Group (LLOY) 74.40p -2.63%Barratt Developments (BDEV) 348.40p -2.60%GKN (GKN) 342.90p -2.39%3i Group (III) 377.70p -2.38%Aggreko (AGK) 1,729.00p -2.26%Sports Direct International (SPD) 670.00p -2.12%Petrofac Ltd. (PFC) 1,089.00p -2.07%FTSE 250 - RisersLaird (LRD) 285.80p +6.76%Hochschild Mining (HOC) 163.40p +2.90%Bodycote (BOY) 710.50p +2.53%Domino's Pizza Group (DOM) 547.00p +1.86%Countrywide (CWD) 524.50p +1.84%Barr (A.G.) (BAG) 661.00p +1.69%Workspace Group (WKP) 607.50p +1.59%Inchcape (INCH) 647.50p +1.57%Thomas Cook Group (TCG) 123.20p +1.07%Rightmove (RMV) 2,258.00p +1.07%FTSE 250 - FallersAfren (AFR) 111.50p -25.07%IP Group (IPO) 181.30p -4.58%Man Group (EMG) 120.50p -4.44%Pace (PIC) 322.60p -4.39%Supergroup (SGP) 1,019.00p -4.23%Bank of Georgia Holdings (BGEO) 2,417.00p -3.09%Homeserve (HSV) 295.30p -2.93%JD Sports Fashion (JD.) 380.10p -2.91%Jupiter Fund Management (JUP) 382.70p -2.87%Ocado Group (OCDO) 333.40p -2.71%BC
More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.